Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Prospektivt Longitudinalt Monocentrisk Studie til Vurdering af Gennemførligheden af Syde® Digitale Endepunkter til Overvågning af Patienter med Progressiv Supranukleær Parese - Richardson Syndrom (PSP-R) (PROSPER-SYDE)

16. november 2026 opdateret af: SYSNAV

Prospektivt longitudinelt monocentrisk studie til evaluering af gennemførligheden af Syde® digitale endpoints til monitorering af patienter med progressiv supranuklear parese - Richardson syndrom (PSP-R)

The study aims to assess the feasibility/acceptability of real-world activity monitoring by the Syde® wearable device in PSP-R. The Syde® collected data will be compared to on-site conventional clinical endpoints, including functional capacity and cognitive assessments, as well as core scales assessments.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Undersøgelsestype

Observationel

Tilmelding (Anslået)

30

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • Paris, Frankrig, 75019
        • Hôpital Fondation Adolphe de Rothschild

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)

Beskrivelse

Inclusion Criteria:

1.18 years old or older

2.Participants affiliated to, or beneficiary from, a social security.

3.Ambulant patients (i.e. able to walk 10 meters without assistance)

4.Signed informed consent form by the patient himself or, by caregivers if the patient is not capable to fill, date and sign the form due to fine motor function difficulties..

5.Possible or probable PSP-R according to MDS criteria 2017(Hoglinger et al., Mov Disorder, 2017).

Exclusion Criteria:

  1. Patients with extreme cognitive disorders that limit their understanding of the data collection process (training of device use and 4-week recording periods every 4 months, device return at the end of the study), tests to be performed including eye movement recording (every 8 months), the implication of the study and consent.
  2. Patients who do not tolerate to keep the sensors on their ankles.
  3. Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the lower limbs.
  4. A concomitant chronic or acute neurological, endocrine, infectious, allergic, or inflammatory pathology within the 3-week period immediately prior to inclusion.
  5. Patients affected by any other disorder having a significant impact on gait or lower limb function.
  6. Participant covered by a legal protection measure (guardianship, curatorship or safeguarding of justice) or who is unable to express their consent.
  7. Absence of caregiver.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol.
Tidsramme: 16 months

Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol (supposed optimal threshold for analysis) at baseline, Month 4, Month 8, Month 12 and Month 16.

16 months
French Usability score (F-SUS) at Month 4 and at the end of the study
Tidsramme: 16 months

Usability score at Month 4 and Month 16. The System Usability Scale is a 10-item questionnaire . It is a simple tool to measure the usability of an interactive system and it is widely used. For each item, the user is asked to express their level of agreement or disagreement from 1 (strongly disagree) and 5 (strongly agree).

16 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from baseline in the total wearing time at months 4, 8, 12, and 16.
Tidsramme: 16 months

Change from baseline in the total wearing time at months 4, 8, 12, and 16.

16 months
Reproducibility of Syde® digital endpoints for each recording period timepoint
Tidsramme: 16 months

Reproducibility of Syde® digital endpoints assessed by the ICC (Intra-Class Correlation) and Bland and Altman analysis for each recording period timepoint (baseline, 4 months, 8 months, 12 months, and 16 months)

16 months
Correlation between Syde® digital endpoints and 2-minute walk test (2MWT)
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and 2MWT

16 months
Correlation between Syde® digital endpoints and 10-meter walk test (10MWT)
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and 10MWT

16 months
Correlation between Syde® digital endpoints and Timed Up and Go (TUG)
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and TUG

16 months
Correlation between Syde® digital endpoints and falls reported by the participants
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and falls reported by the participants

16 months
Correlation between Syde® digital endpoints and Progressive Supranuclear Palsy Rating Scale (PSP-RS)
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and PSP-RS

16 months
Correlation between Syde® digital endpoints and Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS)
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and PSP-CDS

16 months
Correlation between Syde® digital endpoints and Montreal Cognitive Assessment (MoCA)
Tidsramme: 16 months

Correlation at baseline and at different timepoints between Syde® digital endpoints and MoCA

16 months
Longitudinal change in Syde® digital endpoints. The Syde® digital endpoints will include the SV95C (Stride Velocity 95th centile)
Tidsramme: 16 months

Change from baseline in Syde® digital endpoints at 4, 8, 12 and 16 months. The Syde® digital endpoints will include the SV95C (Stride Velocity 95th centile)

16 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Jean-Philippe BRANDEL, Hopital Fondation Adolphe de Rothschild

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. januar 2027

Primær færdiggørelse (Anslået)

1. november 2028

Studieafslutning (Anslået)

1. november 2028

Datoer for studieregistrering

Først indsendt

28. januar 2026

Først indsendt, der opfyldte QC-kriterier

28. januar 2026

Først opslået (Faktiske)

5. februar 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

16. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • PR5030-76
  • 2024-A02611-46 (Anden identifikator: ANSM)

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .